The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Triptans in migraine: The risks of stroke, cardiovascular disease, and death in practice
Abstract
BACKGROUND: Triptans are widely used to treat migraine but have been associated with stroke, myocardial infarction (MI), and ischemic heart disease (IHD) in case reports. OBJECTIVE: To estimate the incidence of stroke, cardiovascular events, and death in a migraine cohort, stratified by triptan prescription, and investigate whether the risk of these events was increased in those treated with triptans. METHODS: Migraine patients and matched nonmigraine control subjects were identified from the General Practice Research Database. Computerized records were searched for triptan prescriptions, stroke, TIA, MI, IHD, death, arrhythmia, and confounding variables. Incidence rates were calculated and migraine groups compared with controls using a Cox model, adjusting for confounders. RESULTS: Of 63,575 migraine patients, 13,664 were prescribed a triptan. There was no association between triptan prescription and stroke (hazard ratio [HR] 1.13; 95% CI 0.78, 1.65), MI (HR 0.93; 95% CI 0.60, 1.43), or other outcomes studied. The larger group of migraine patients not prescribed a triptan had an increased risk of stroke (HR 1.51; 95% CI 1.26, 1.82) and IHD (HR 1.35; 95% CI 1.18, 1.54) and a decreased risk of all-cause mortality (HR 0.72; 95% CI 0.65, 0.80). CONCLUSIONS: In general practice, triptan treatment in migraine does not increase the risk of stroke, MI, cardiovascular death, IHD, or mortality. Triptans are prescribed to those less at risk of these events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sorge, F., Simone, R. D., Marano, E., Nolano, M., Orefice, G., & Carrieri, P. (1988) · Cephalalgia · doi:10.1046/j.1468-2982.1988.0801001.x · Cited by 3,465
Stewart, W. F. (1992) · JAMA · doi:10.1001/jama.267.1.64 · Cited by 1,583
Lung Cancer and Cryptogenic Fibrosing Alveolitis: A Population-based Cohort Study
HUBBARD, R., VENN, A., LEWIS, S., & BRITTON, J. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.1.9906062 · Cited by 639
Use of the UK General Practice Research Database for pharmacoepidemiology
García Rodríguez, L. A., & Pérez Gutthann, S. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00701.x · Cited by 558
Case-control study of migraine and risk of ischaemic stroke in young women
Tzourio, C., Tehindrazanarivelo, A., Iglesias, S., Alperovitch, A., Chedru, F., d'Anglejan-Chatillon, J., & Bousser, M.-G. (1995) · BMJ · doi:10.1136/bmj.310.6983.830 · Cited by 511
Migraine and stroke in young women: case-control study
Chang, C. L., Donaghy, M., & Poulter, N. (1999) · BMJ · doi:10.1136/bmj.318.7175.13 · Cited by 475
Medical Consultation for Migraine: Results From the American Migraine Study
Lipton, R. B., Stewart, W. F., & Simon, D. (1998) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.1998.3802087.x · Cited by 370
History of migraine and risk of cerebral ischaemia in young adults
Italian National Research Council Study Group on Stroke in the Young, Carolei, A., Marini, C., & De Matteis, G. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90669-8 · Cited by 336
The Natural History of CADASIL: A Pooled Analysis of Previously Published Cases
Desmond, D. W., Moroney, J. T., Lynch, T., Chan, S., Chin, S. S., & Mohr, J. P. (1999) · Stroke · doi:10.1161/01.str.30.6.1230 · Cited by 269
Is Variant Angina the Coronary Manifestation of a Generalized Vasospastic Disorder?
Miller, D., Waters, D. D., Warnica, W., Szlachcic, J., Kreeft, J., & Théroux, P. (1981) · New England Journal of Medicine · doi:10.1056/nejm198103263041306 · Cited by 249
Cited by
EFNS guideline on the drug treatment of migraine—revised report of an EFNS task force
Evers, S., Áfra, J., Frese, A., Goadsby, P. J., Linde, M., May, A., & Sándor, P. S. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02748.x · Cited by 892
Migraine and Risk of Cardiovascular Disease in Women
Kurth, T., Gaziano, J. M., Cook, N. R., Logroscino, G., Diener, H.-C., & Buring, J. E. (2006) · JAMA · doi:10.1001/jama.296.3.283 · Cited by 580
Migraine Headache and Ischemic Stroke Risk: An Updated Meta-analysis
Spector, J. T., Kahn, S. R., Jones, M. R., Jayakumar, M., Dalal, D., & Nazarian, S. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.12.021 · Cited by 414
Herrett, E., Shah, A. D., Boggon, R., Denaxas, S., Smeeth, L., van Staa, T., Timmis, A., & Hemingway, H. (2013) · BMJ · doi:10.1136/bmj.f2350 · Cited by 369
5-Hydroxytryptamine receptors in the human cardiovascular system
Kaumann, A. J., & Levy, F. O. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.12.004 · Cited by 309
Metadata
- Authors
- Hall, G. C., Brown, M. M., Mo, J., & MacRae, K. D.
- Venue
- Neurology
- Published
- 2004-02-24
- Volume
- 62
- Issue
- 4
- Pages
- 563-568
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2003313582
- Cited by
- 296
- References
- 21
- FWCI
- 10.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Triptans in migraine: The risks of stroke, cardiovascular disease, and death in practice. https://app.cochat.ai/papers/10.1212/01.wnl.0000110312.36809.7f
- The paper
- Hall, G. C., Brown, M. M., Mo, J., & MacRae, K. D. (2004). Triptans in migraine: The risks of stroke, cardiovascular disease, and death in practice. Neurology. https://doi.org/10.1212/01.wnl.0000110312.36809.7f
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.